Originally published as JCO Early Release 10.1200/JCO.2005.03.2235 on January 17 2006
Journal of Clinical Oncology, Vol 24, No 6 (February 20), 2006: pp. 848-855
© 2006 American Society of Clinical Oncology.
Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
Eva Grunfeld,
Mark N. Levine,
Jim A. Julian,
Doug Coyle,
Barbara Szechtman,
Doug Mirsky,
Shailendara Verma,
Susan Dent,
Carol Sawka,
Kathleen I. Pritchard,
David Ginsburg,
Marjorie Wood,
Tim Whelan
From the Cancer Outcomes Research Program, Cancer Care Nova Scotia and Dalhousie University, Halifax, Nova Scotia; Ottawa Regional Cancer Centre and University of Ottawa; Ottawa Hospital and University of Ottawa, Ottawa; Ontario Clinical Oncology Group; Juravinski Regional Cancer Centre and McMaster University; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton; Toronto-Sunnybrook Regional Cancer Centre and University of Toronto, Toronto; Northwestern Ontario Regional Cancer Centre, Thunder Bay; Kingston Regional Cancer Centre, Kingston, Ontario; and University of British Columbia, Vancouver, British Columbia, Canada
Address reprint requests to E. Grunfeld, MD, DPhil, Cancer Care Nova Scotia and Division of Medical Oncology, Dalhousie University, 1278 Tower Route, 5th Floor Bethune Building, Halifax, Nova Scotia, Canada B3H 2Y9; e-mail: Eva.Grunfeld{at}ccns.nshealth.ca
PURPOSE: Most women with breast cancer are diagnosed at an early stage and more than 80% will be long-term survivors. Routine follow-up marks the transition from intensive treatment to survivorship. It is usual practice for routine follow-up to take place in specialist clinics. This study tested the hypothesis that follow-up by the patient's family physician is a safe and acceptable alternative to specialist follow-up.
PATIENTS AND METHODS: A multicenter, randomized, controlled trial was conducted involving 968 patients with early-stage breast cancer who had completed adjuvant treatment, were disease free, and were between 9 and 15 months after diagnosis. Patients may have continued receiving adjuvant hormonal therapy. Patients were randomly allocated to follow-up in the cancer center according to usual practice (CC group) or follow-up from their own family physician (FP group). The primary outcome was the rate of recurrence-related serious clinical events (SCEs). The secondary outcome was health-related quality of life (HRQL).
RESULTS: In the FP group, there were 54 recurrences (11.2%) and 29 deaths (6.0%). In the CC group, there were 64 recurrences (13.2%) and 30 deaths (6.2%). In the FP group, 17 patients (3.5%) compared with 18 patients (3.7%) in the CC group experienced an SCE (0.19% difference; 95% CI, 2.26% to 2.65%). No statistically significant differences (P < .05) were detected between groups on any of the HRQL questionnaires.
CONCLUSION: Breast cancer patients can be offered follow-up by their family physician without concern that important recurrence-related SCEs will occur more frequently or that HRQL will be negatively affected.
Supported by Grant No. 010413 from the Canadian Breast Cancer Research Alliance. While conducting this study, Dr Grunfeld was a Career Scientist with the Ontario Ministry of Health and Long-term Care. The conclusions are those of the authors and no endorsement by the Ministry is intended or should be inferred.
Presented as a poster at the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Related Editorial
- Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
James L. Khatcheressian and Thomas J. Smith
JCO 2006 24: 835-837
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
E. Grunfeld
Primary Care Physicians and Oncologists Are Players on the Same Team
J. Clin. Oncol.,
May 10, 2008;
26(14):
2246 - 2247.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Snyder, C. C. Earle, R. J. Herbert, B. A. Neville, A. L. Blackford, and K. D. Frick
Preventive Care for Colorectal Cancer Survivors: A 5-Year Longitudinal Study
J. Clin. Oncol.,
March 1, 2008;
26(7):
1073 - 1079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Ganz and E. E. Hahn
Implementing a Survivorship Care Plan for Patients With Breast Cancer
J. Clin. Oncol.,
February 10, 2008;
26(5):
759 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Donnelly, L Hiller, S Bathers, S Bowden, and R Coleman
Questioning specialists' attitudes to breast cancer follow-up in primary care
Ann. Onc.,
September 1, 2007;
18(9):
1467 - 1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Keating, M. B. Landrum, E. Guadagnoli, E. P. Winer, and J. Z. Ayanian
Surveillance Testing Among Survivors of Early-Stage Breast Cancer
J. Clin. Oncol.,
March 20, 2007;
25(9):
1074 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Liberato, M. Marchetti, and G. Barosi
Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
J. Clin. Oncol.,
February 20, 2007;
25(6):
625 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Earle
Failing to Plan Is Planning to Fail: Improving the Quality of Care With Survivorship Care Plans
J. Clin. Oncol.,
November 10, 2006;
24(32):
5112 - 5116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Oeffinger and M. S. McCabe
Models for Delivering Survivorship Care
J. Clin. Oncol.,
November 10, 2006;
24(32):
5117 - 5124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Z. Ayanian and P. B. Jacobsen
Enhancing Research on Cancer Survivors
J. Clin. Oncol.,
November 10, 2006;
24(32):
5149 - 5153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grunfeld
Looking Beyond Survival: How Are We Looking at Survivorship?
J. Clin. Oncol.,
November 10, 2006;
24(32):
5166 - 5169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Khatcheressian, A. C. Wolff, T. J. Smith, E. Grunfeld, H. B. Muss, V. G. Vogel, F. Halberg, M. R. Somerfield, and N. E. Davidson
American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting
J. Clin. Oncol.,
November 1, 2006;
24(31):
5091 - 5097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Other articles noted
Evid. Based Med.,
October 1, 2006;
11(5):
159 - 160.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grunfeld, M. N. Levine, and J. A. Julian
In Reply
J. Clin. Oncol.,
August 1, 2006;
24(22):
3711 - 3712.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Warner and J. Weinroth
Family Physician Versus Specialist Care for Breast Cancer Follow-Up
J. Clin. Oncol.,
August 1, 2006;
24(22):
3710 - 3710.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Q. Rosenzweig
The Oncology Nurse Practitioner: A Unique Provider for the Follow-Up for Early-Stage Breast Cancer
J. Clin. Oncol.,
August 1, 2006;
24(22):
3710 - 3711.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Khatcheressian and T. J. Smith
Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
J. Clin. Oncol.,
February 20, 2006;
24(6):
835 - 837.
[Full Text]
[PDF]
|
 |
|
|